LRI Investments LLC acquired a new position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) in the 1st quarter, Holdings Channel reports. The institutional investor acquired 622 shares of the medical research company’s stock, valued at approximately $157,000.
Several other hedge funds have also recently bought and sold shares of the stock. Quadrature Capital Ltd acquired a new position in IQVIA during the first quarter worth $3,365,000. Stonebridge Capital Advisors LLC lifted its stake in IQVIA by 5.5% in the 1st quarter. Stonebridge Capital Advisors LLC now owns 10,056 shares of the medical research company’s stock valued at $2,543,000 after acquiring an additional 520 shares in the last quarter. Canada Pension Plan Investment Board lifted its stake in IQVIA by 6.4% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,191,835 shares of the medical research company’s stock valued at $807,183,000 after acquiring an additional 193,304 shares in the last quarter. Capital Research Global Investors lifted its stake in IQVIA by 7.2% in the 1st quarter. Capital Research Global Investors now owns 2,138,802 shares of the medical research company’s stock valued at $540,882,000 after acquiring an additional 143,533 shares in the last quarter. Finally, Advisors Asset Management Inc. lifted its stake in IQVIA by 106.4% in the 1st quarter. Advisors Asset Management Inc. now owns 1,298 shares of the medical research company’s stock valued at $328,000 after acquiring an additional 669 shares in the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.
IQVIA Trading Up 3.2 %
IQV stock traded up $7.38 during trading on Friday, hitting $239.67. 1,195,238 shares of the company traded hands, compared to its average volume of 1,420,984. The firm has a market capitalization of $43.69 billion, a PE ratio of 32.74, a P/E/G ratio of 2.26 and a beta of 1.49. IQVIA Holdings Inc. has a 1 year low of $167.42 and a 1 year high of $261.73. The company has a 50-day moving average of $220.23 and a 200-day moving average of $229.46. The company has a debt-to-equity ratio of 1.80, a quick ratio of 0.88 and a current ratio of 0.85.
Wall Street Analysts Forecast Growth
IQV has been the topic of several recent analyst reports. Truist Financial boosted their price target on IQVIA from $292.00 to $300.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. StockNews.com raised IQVIA from a “hold” rating to a “buy” rating in a research report on Monday, July 15th. Barclays boosted their price target on IQVIA from $255.00 to $275.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 23rd. Jefferies Financial Group lowered IQVIA from a “buy” rating to a “hold” rating and decreased their target price for the stock from $266.00 to $242.00 in a report on Wednesday. Finally, Morgan Stanley boosted their price target on IQVIA from $270.00 to $280.00 and gave the company an “overweight” rating in a research note on Tuesday, July 23rd. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $263.56.
View Our Latest Stock Report on IQVIA
IQVIA Profile
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Recommended Stories
- Five stocks we like better than IQVIA
- What is the Shanghai Stock Exchange Composite Index?
- Is Crypto Cool Again? What Stocks You Should Be Watching
- What is a Secondary Public Offering? What Investors Need to Know
- Why Call Options Volume for These 2 Stocks Spiked Together
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MarketBeat Week in Review – 7/22 – 7/26
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Free Report).
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.